APD | action potential duration |
IPoC | ischemic postconditioning |
PKC | protein kinase C |
KATP | ATP-dependent potassium channels |
Cx32 | connexin 32 |
Cx43 | connexin 43 |
CPT | adenosine A1 receptor antagonist, cyclopentyl theophylline |
SCH | adenosine A2A receptor antagonist, SCH 58261 |
MRS | adenosine A3 receptor antagonist, MRS-1523 |
GLI | non selective KATP blocker, glibenclamide |
LY | Licifer Yellow |
RD | Rhodamine |